Roberto Mignone

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
6 years
Director since
2023

6 years of board service in total across 2 boards, counting each seat separately. Longest: Teva Pharmaceutical Industries Limited, 3 years.

3 years · Since 2023
2 years · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 21, 2026 Guardant Health Inc. Option exercise +264 — —
Sep 21, 2026 Guardant Health Inc. Option exercise +264 — —
Sep 18, 2026 Teva Pharmaceutical Industries Limited Open-market sale −367,600 $39.06 $14,358,456
Aug 21, 2026 Guardant Health Inc. Option exercise +264 — —
Jul 21, 2026 Guardant Health Inc. Option exercise +264 — —
Jun 21, 2026 Guardant Health Inc. Option exercise +264 — —
Jun 17, 2026 Guardant Health Inc. Option exercise +4,203 — —
Jun 5, 2026 Teva Pharmaceutical Industries Limited Option exercise +14,492 — —
May 21, 2026 Guardant Health Inc. Option exercise +264 — —
Apr 21, 2026 Guardant Health Inc. Option exercise +264 — —
Mar 21, 2026 Guardant Health Inc. Option exercise +264 — —
Feb 21, 2026 Guardant Health Inc. Option exercise +264 — —
Jan 21, 2026 Guardant Health Inc. Option exercise +264 — —
Dec 21, 2025 Guardant Health Inc. Option exercise +264 — —
Dec 16, 2025 Teva Pharmaceutical Industries Limited Open-market sale −77,400 $30.24 $2,340,576

Questions about Roberto Mignone

What boards is Roberto Mignone on?

Roberto Mignone sits on the boards of Guardant Health Inc. and Teva Pharmaceutical Industries Limited.

How long has Roberto Mignone served on boards?

Our records show at least 6 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.